| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 达嘉维康 | 420.62 | 减持 | 流通A股 | 2.05% | 2025-09-30 |
| 2 | 达嘉维康 | 544.62 | 减持 | 流通A股 | 2.65% | 2025-06-30 |
| 3 | 达嘉维康 | 546.62 | 未变 | 流通A股 | 2.66% | 2025-03-31 |
| 4 | 达嘉维康 | 546.62 | 减持 | 流通A股 | 2.66% | 2024-12-31 |
| 5 | 达嘉维康 | 636.53 | 减持 | 流通A股 | 3.1% | 2024-09-30 |
| 6 | 达嘉维康 | 666.53 | 减持 | 流通A股 | 3.23% | 2024-06-30 |
| 7 | 达嘉维康 | 673.53 | 未变 | 流通A股 | 3.26% | 2024-04-10 |
| 8 | 达嘉维康 | 673.53 | 未变 | 流通A股 | 3.26% | 2024-03-31 |
| 9 | 达嘉维康 | 673.53 | 未变 | 流通A股 | 3.26% | 2024-03-28 |
| 10 | 达嘉维康 | 673.53 | 减持 | 流通A股 | 3.26% | 2023-12-31 |
| 11 | 达嘉维康 | 785.53 | 减持 | 流通A股 | 3.8% | 2023-09-30 |
| 12 | 达嘉维康 | 863.97 | 减持 | 流通A股 | 4.18% | 2023-06-30 |
| 13 | 达嘉维康 | 931.53 | 未变 | 流通A股 | 4.51% | 2023-03-31 |
| 14 | 达嘉维康 | 931.53 | 未变 | 流通A股 | 4.51% | 2022-12-31 |
| 15 | 达嘉维康 | 931.53 | 未变 | 限售流通股 | 4.51% | 2022-09-30 |
| 16 | 达嘉维康 | 931.53 | 未变 | 4.51% | 2022-06-30 | |
| 17 | 达嘉维康 | 931.53 | 未变 | 限售流通股 | 4.51% | 2022-03-31 |
| 18 | 达嘉维康 | 931.53 | 未变 | 限售流通股 | 4.51% | 2021-12-31 |
| 19 | 达嘉维康 | 931.53 | 未变 | 4.51% | 2021-12-07 | |
| 20 | 达嘉维康 | 931.53 | 新进 | 限售流通股 | 6.01% | 2021-11-26 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 达嘉维康 | 420.62 | 减持 | 境内法人股 | 3.051% | 2025-09-30 |
| 2 | 达嘉维康 | 544.62 | 减持 | 境内法人股 | 3.95% | 2025-06-30 |
| 3 | 达嘉维康 | 546.62 | 未变 | 境内法人股 | 3.964% | 2025-03-31 |
| 4 | 达嘉维康 | 546.62 | 减持 | 境内法人股 | 3.964% | 2024-12-31 |
| 5 | 达嘉维康 | 636.53 | 减持 | 境内法人股 | 5.86% | 2024-09-30 |
| 6 | 达嘉维康 | 666.53 | 减持 | 境内法人股 | 6.075% | 2024-06-30 |
| 7 | 达嘉维康 | 673.53 | 未变 | 境内法人股 | 6.138% | 2024-04-10 |
| 8 | 达嘉维康 | 673.53 | 未变 | 境内法人股 | 6.138% | 2024-03-31 |
| 9 | 达嘉维康 | 673.53 | 未变 | 境内法人股 | 6.189% | 2024-03-28 |
| 10 | 达嘉维康 | 673.53 | 减持 | 境内法人股 | 6.189% | 2023-12-31 |
| 11 | 达嘉维康 | 785.53 | 减持 | 境内法人股 | 7.219% | 2023-09-30 |
| 12 | 达嘉维康 | 863.97 | 减持 | 境内法人股 | 7.939% | 2023-06-30 |
| 13 | 达嘉维康 | 931.53 | 未变 | 境内法人股 | 8.596% | 2023-03-31 |
| 14 | 达嘉维康 | 931.53 | 新进 | 境内法人股 | 8.596% | 2022-12-31 |
![]() |
![]() |